Explore how next-generation sequencing (NGS) is advancing the detection and characterization of respiratory RNA viruses in clinical development.

This webinar examines the challenges of analyzing low viral load clinical samples and highlights strategies for developing and validating sensitive, reliable NGS-based assays. Learn how whole-genome sequencing (WGS) and optimized sequencing workflows improve viral detection, strain identification, and genomic surveillance to support clinical research and public health initiatives.

In this webinar, you'll learn:

• The challenges of analyzing low viral load samples using NGS
• Strategies for developing and validating robust NGS assays for respiratory RNA viruses
• Key considerations when selecting whole-genome sequencing, probe-based, or amplicon sequencing approaches
• How NGS supports viral surveillance, outbreak monitoring, and clinical decision-making

As infectious disease research continues to evolve, robust NGS workflows are essential for generating accurate genomic data and identifying emerging viral variants. Discover how optimized sequencing strategies are improving viral characterization and supporting clinical development, surveillance, and public health response.